Advertisement

Reactions Weekly

, Volume 1640, Issue 1, pp 78–78 | Cite as

Cabergoline

Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: case report
Case report

Reference

  1. Chouchana L, et al. Neurovascular adverse effects following cabergoline administration in puerperal period. Fundamental and Clinical Pharmacology 30 (Suppl. 1): 27-28 abstr. PM1-013, Apr 2016. Available from: URL: http://doi.org/10.1111/fcp.12189 [abstract] - France

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations